Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 2, 2014
Dr. Iacone describes the incorporation of iPSC-derived iCell® and MyCell® Cardiomyocytes into their research program in diabetic cardiomyopathy associated with Type II diabetes and how these cells may enable development of personalized medicine.